Junchen Yang

Junchen Yang, Ofir Lindenbaum, Yuval Kluger et al.

Multi-modal high throughput biological data presents a great scientific opportunity and a significant computational challenge. In multi-modal measurements, every sample is observed simultaneously by two or more sets of sensors. In such settings, many observed variables in both modalities are often nuisance and do not carry information about the phenomenon of interest. Here, we propose a multi-modal unsupervised feature selection framework: identifying informative variables based on coupled high-dimensional measurements. Our method is designed to identify features associated with two types of latent low-dimensional structures: (i) shared structures that govern the observations in both modalities and (ii) differential structures that appear in only one modality. To that end, we propose two Laplacian-based scoring operators. We incorporate the scores with differentiable gates that mask nuisance features and enhance the accuracy of the structure captured by the graph Laplacian. The performance of the new scheme is illustrated using synthetic and real datasets, including an extended biological application to single-cell multi-omics.

Junchen Yang, Ofir Lindenbaum, Yuval Kluger

Tabular datasets with low-sample-size or many variables are prevalent in biomedicine. Practitioners in this domain prefer linear or tree-based models over neural networks since the latter are harder to interpret and tend to overfit when applied to tabular datasets. To address these neural networks' shortcomings, we propose an intrinsically interpretable network for heterogeneous biomedical data. We design a locally sparse neural network where the local sparsity is learned to identify the subset of most relevant features for each sample. This sample-specific sparsity is predicted via a \textit{gating} network, which is trained in tandem with the \textit{prediction} network. By forcing the model to select a subset of the most informative features for each sample, we reduce model overfitting in low-sample-size data and obtain an interpretable model. We demonstrate that our method outperforms state-of-the-art models when applied to synthetic or real-world biomedical datasets using extensive experiments. Furthermore, the proposed framework dramatically outperforms existing schemes when evaluating its interpretability capabilities. Finally, we demonstrate the applicability of our model to two important biomedical tasks: survival analysis and marker gene identification.